
Mesoestetic Blemiderm Local Control spot gel for imperfections 10ml
40,00 €
Add to cartMesoestetic Blemiderm Local Control spot gel for imperfections 10ml
40,00 €
The spot treatment for imperfections was created to combat acne and reduce skin inflammation. This product has antibacterial, anti-inflammatory and acne-relieving properties.
-
Delivery Return
Delivery
Products are shipped within the European Union.
Delivery time: 1 to 7 business days depending on the destination country.
Delivery options and costs are displayed during checkout.Return
Customers have the right to complain about defective products.
Complaints should be submitted via e-mail to: info@aestheticmedicine.shop
Complaints are reviewed within 14 business days.Help
- Give us a shout if you have any other questions and/or concerns.
- Email: info@aestheticmedicine.shop
-
Ask a Question
Ask a Question
Mesoestetic Blemiderm Local Control spot gel for imperfections 10ml
40,00 €If this description is not sufficient, please send us a question to this product. We will reply as soon as possible.

Free
Shipping in Europe
for orders over 1000 €
100%
Guaranteed
Satisfaction
Safe
Stripe
Payments
Mesoestetic Blemiderm Local Control 10 ml
A spot treatment for imperfections was created to combat acne and reduce skin inflammation. This product has antibacterial, anti-inflammatory effects and soothes the symptoms of acne, such as redness, pimples and blackheads. Concentrated AHA and BHA formula that unblocks and cleanses pores. The combination of enoxolone and niacinamide helps reduce swelling and redness and prevents the appearance of acne discolorations.
Indications:
- Oily, combination and acne skin
- Inflammation
- Blackheads
- Swelling
- Redness
Active ingredients:
- glycolic acid
- mandelic acid
- salicylic acid
- enoxolone
- niacinamide
How to use:
Apply a small amount of the product in the evening to cleansed and dry facial skin, directly to the pimple or area of changes.
Packaging: 10 ml tube
You must be logged in to post a review.
Reviews
There are no reviews yet.